http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106474495-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0478 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-082 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08 |
| filingDate | 2016-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106474495-B |
| titleOfInvention | Imido- oxalic acid99mThe rgd peptide cancer diagnosis drug and preparation method thereof of Tc label |
| abstract | The present invention provides a kind of using iminodiacetic acid as bifunctional linking reagent 99m Tc complex, shown in structure such as following formula (1).The compounds of this invention has the characteristics that prepare that simple, cheap, mark rate and radiochemical purity are high, target to non-target ratio value is high, tumor uptake value is high and the residence time is long, liver kidney background is low, novel technetium-99 m labeled is used for intergrin α as a kind of v β 3 The imaging agent of receptor positive tumor diagnosis is applied in radiopharmaceutical chemistry and clinical nuclear medicine technical field. |
| priorityDate | 2016-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.